🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of aficamt...
Status
Completed
Location
Alaska Heart and Vascular Institute
Start Date
2022-02-01
Trial ID
NCT05186818
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, safety and pharmacok...
Status
Active Not Recruiting
Location
Phoenix Children's Hospital
Start Date
2024-05-29
Trial ID
NCT06412666
The purpose of this study is to collect long-term safety and tolerability d...
Status
Enrolling By Invitation
Location
University of Alabama at Birmingham
Start Date
2021-05-06
Trial ID
NCT04848506
Treatments Being Tested
The purposes of this study are to: 1. Learn about the safety of CK-3773274...
Status
Completed
Location
Clinical Site
Start Date
2021-04-10
Trial ID
NCT04783766
Treatments Being Tested
The purposes of this study are to: 1. Learn about the safety of CK-3773274...
Status
Completed
Location
Clinical Site
Start Date
2018-12-04
Trial ID
NCT03767855
Treatments Being Tested
Researchers are looking for a better way to treat Japanese people who have ...
Status
Active Not Recruiting
Location
Kurume University Hospital
Start Date
2025-06-30
Trial ID
NCT07023341
Treatments Being Tested
This clinical trial will study the effects of aficamten (versus placebo) on...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2023-08-31
Trial ID
NCT06081894
This is a single-center, 2-part (Part A and Part B) study in healthy partic...
Status
Completed
Location
Celerion, Inc 2420
Start Date
2023-05-15
Trial ID
NCT05924815
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of aficamte...
Status
Completed
Location
Alaska Heart and Vascular Institute
Start Date
2023-06-20
Trial ID
NCT05767346
This is an open-label extension study of China cohort in the phase 3 study ...
Status
Completed
Location
Beijing Anzhen Hospital
Start Date
2023-11-14
Trial ID
NCT06116968
Treatments Being Tested